AZ and Daiichi to file new breast cancer drug after trial success

AZ and Daiichi to file new breast cancer drug after trial success

Source: 
Pharmaforum
snippet: 

In March AstraZeneca asked investors for $3.5 billion to fund a collaboration with Daiichi Sankyo over a new breast cancer drug – and it looks like the project is on track.